Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2013 (2013), Article ID 472041, 8 pages
http://dx.doi.org/10.1155/2013/472041
Research Article

Nontuberculous Mycobacteria in Guadeloupe, Martinique, and French Guiana from 1994 to 2012

WHO Supranational TB Reference Laboratory, Tuberculosis & Mycobacteria Unit, Institut Pasteur de la Guadeloupe, Morne Jolivière, BP 484, 97183 Les Abymes, France

Received 20 September 2013; Accepted 30 October 2013

Academic Editor: Carlo Garzelli

Copyright © 2013 Elisabeth Streit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Euzéby and A. C. Parte, List of Prokaryotic Names With Standing in Nomenclature, 2013.
  2. J. O. Falkinham III, “Nontuberculous mycobacteria in the environment,” Clinics in Chest Medicine, vol. 23, no. 3, pp. 529–551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. M. Vaerewijck, G. Huys, J. C. Palomino, J. Swings, and F. Portaels, “Mycobacteria in drinking water distribution systems: ecology and significance for human health,” FEMS Microbiology Reviews, vol. 29, no. 5, pp. 911–934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Wagner and L. S. Young, “Nontuberculous mycobacterial infections: a clinical review,” Infection, vol. 32, no. 5, pp. 257–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Katoch, “Infections due to non-tuberculous mycobacteria (NTM),” Indian Journal of Medical Research, vol. 120, no. 4, pp. 290–304, 2004. View at Google Scholar · View at Scopus
  6. T. K. Marras and C. L. Daley, “Epidemiology of human pulmonary infection with nontuberculous mycobacteria,” Clinics in Chest Medicine, vol. 23, no. 3, pp. 553–567, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Martín-Casabona, A. R. Bahrmand, J. Bennedsen et al., “Non-tuberculous mycobacteria: Patterns of isolation. A multi-country retrospective survey,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 10, pp. 1186–1193, 2004. View at Google Scholar · View at Scopus
  8. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Hoefsloot, J. van Ingen, C. Andrejak et al. et al., “The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study,” European Respiratory Journal, vol. 42, no. 6, pp. 1604–1613, 2013. View at Publisher · View at Google Scholar
  10. N. Rastogi, K. S. Goh, N. Guillou, and V. Labrousse, “Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs?” Zentralblatt fur Bakteriologie, vol. 277, no. 4, pp. 474–484, 1992. View at Google Scholar · View at Scopus
  11. A. Devallois, K. S. G. Goh, and N. Rastogi, “Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species,” Journal of Clinical Microbiology, vol. 35, no. 11, pp. 2969–2973, 1997. View at Google Scholar · View at Scopus
  12. J. Cuzick, “A Wilcoxon-type test for trend,” Statistics in Medicine, vol. 4, no. 1, pp. 87–90, 1985. View at Google Scholar · View at Scopus
  13. E. Legrand, C. Sola, B. Verdol, and N. Rastogi, “Genetic diversity of Mycobacterium avium recovered from AIDS patients in the Caribbean as studied by a consensus IS1245-RFLP method and pulsed-field gel electrophoresis,” Research in Microbiology, vol. 151, no. 4, pp. 271–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Legrand, A. Devallois, L. Horgen, and N. Rastogi, “A molecular epidemiological study of Mycobacterium simiae isolated from AIDS patients in Guadeloupe,” Journal of Clinical Microbiology, vol. 38, no. 8, pp. 3080–3084, 2000. View at Google Scholar · View at Scopus
  15. E. Legrand, K. Goh, C. Sola, and N. Rastogi, “Description of a novel Mycobacterium simiae allelic variant isolated from Caribbean AIDS patients by PCR-restriction enzyme analysis and sequencing of hsp65 gene,” Molecular and Cellular Probes, vol. 14, no. 6, pp. 355–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Y. Han, J. J. Tarrand, R. Infante, K. L. Jacobson, and M. Truong, “Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS,” Journal of Clinical Microbiology, vol. 43, no. 9, pp. 4407–4412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Simons, J. van Ingen, P.-R. Hsueh et al., “Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia,” Emerging Infectious Diseases, vol. 17, no. 3, pp. 343–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Daley and D. E. Griffith, “Pulmonary disease caused by rapidly growing mycobacteria,” Clinics in Chest Medicine, vol. 23, no. 3, pp. 623–632, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Legrand, N. Radegonde, K. S. Goh, and N. Rastogi, “A pulsed-field gel electrophoresis study of Mycobacterium fortuitum in a Caribbean setting underlines high genetic diversity of the strains and excludes nosocomial outbreaks,” International Journal of Medical Microbiology, vol. 292, no. 1, pp. 51–57, 2002. View at Google Scholar · View at Scopus
  20. S. Park, G. Y. Suh, M. P. Chung et al., “Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens,” Respiratory Medicine, vol. 102, no. 3, pp. 437–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. C. Bloch, L. Zwerling, M. J. Pletcher et al., “Incidence and clinical implications of isolation of Mycobacterium kansasii results of a 5-year, population-based study,” Annals of Internal Medicine, vol. 129, no. 9, pp. 698–704, 1998. View at Google Scholar · View at Scopus
  22. B. A. Brown-Elliott and R. J. Wallace Jr., “Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 716–746, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Petrini, “Mycobacterium abscessus: an emerging rapid-growing potential pathogen,” APMIS, vol. 114, no. 5, pp. 319–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. K. A. Nash, A. B. Brown-Elliott, and R. J. Wallace, “A Novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from mycobacterium chelonae,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1367–1376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ferdinand, E. Legrand, K. S. Goh et al., “Taxonomic and phylogenetic status of non-tuberculous mycobacteria in a Caribbean setting,” Molecular and Cellular Probes, vol. 18, no. 6, pp. 399–408, 2004. View at Publisher · View at Google Scholar · View at Scopus